OTC:RAPH | Free Cash Flow | Raphael Pharmaceutical Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$44,000.00
2025-12-31$46,000.00
2025-03-31-$209,000.00
2024-12-31-$62,000.00
2024-03-31-$172,000.00$1,000.00-$173,000.00
2023-12-31-$88,000.00
2023-03-31-$399,000.00
2022-12-31-$277,000.00
2022-03-31-$82,000.00
2021-12-31-$703,000.00
2021-03-31-$129,000.00
2020-12-31-$468,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$210,000.00
2024-12-31-$532,000.00
2023-12-31-$1.2M
2022-12-31-$759,000.00$2,000.00-$761,000.00
2021-12-31-$1.42M
2020-12-31-$779,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.